These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36816030)

  • 1. Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma.
    Tang Y; Ye C; Zeng J; Zhu P; Cheng S; Zeng W; Yang B; Liu Y; Yu Y
    Front Genet; 2023; 14():1038924. PubMed ID: 36816030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients.
    Tao J; Li X; Liang C; Liu Y; Zhou J
    Front Oncol; 2022; 12():1026331. PubMed ID: 36353536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 20-Gene Signature Predicting Survival in Patients with Clear Cell Renal Cell Carcinoma Based on Basement Membrane.
    Yin Z; Zhao Y; Zhou W; You C; Bai Y; You B; Lu D; Liao S; Zheng L; Sun Y; Wu Y
    J Oncol; 2023; 2023():1302278. PubMed ID: 37089260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
    Zhou Q; Sun Q; Shen Q; Li X; Qian J
    Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.
    Zhou T; Chen W; Wu Z; Cai J; Zhou C
    Front Genet; 2022; 13():994208. PubMed ID: 36186476
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma.
    Yao Q; Zhang X; Wei C; Chen H; Xu Q; Chen J; Chen D
    Heliyon; 2023 Jun; 9(6):e17224. PubMed ID: 37360096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma.
    Pan H; Lu W; Zhang M; Liu C
    Front Oncol; 2023; 13():1131191. PubMed ID: 37182129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma.
    Zhao G; Zheng J; Tang K; Chen Q
    Front Genet; 2022; 13():1058207. PubMed ID: 36544490
    [No Abstract]   [Full Text] [Related]  

  • 13. Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma.
    Xia B; Wang J; Zhang D; Hu X
    Sci Rep; 2024 Feb; 14(1):3893. PubMed ID: 38365923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
    Front Genet; 2022; 13():787884. PubMed ID: 35350243
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma.
    Tang F; Tang Z; Lu Z; Cai Y; Lai Y; Mai Y; Li Z; Lu Z; Zhang J; Li Z; He Z
    BMC Urol; 2022 Dec; 22(1):203. PubMed ID: 36496360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance, molecular characterization, and immune microenvironment analysis of coagulation-related genes in clear cell renal cell carcinoma.
    Chen W; Zhao X; Lu Y; Wang H; Wang X; Wang Y; Liang C; Jia Z; Ma W
    Cancer Innov; 2024 Feb; 3(1):e105. PubMed ID: 38948537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes.
    Qian C; Sun Y; Di S; Wang H; Tian Y; Wang C; Cui X
    Transl Androl Urol; 2023 Apr; 12(4):659-672. PubMed ID: 37181236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
    Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.